左炔诺孕酮宫内缓释系统治疗功能失调性子宫出血及子宫内膜增生过长临床疗效研究  

Clinical Efficacy of Levonorgestrel Intrauterine Sustained Release System in the Treatment of Dysfunctional Uterine Bleeding and Endometrial Hyperplasia

作　　者：余军辉 朱雪琼[2] Yu Junhui;Zhu Xueqiong(Department of Obstetrics and Gynecology,Taizhou Hospital Affiliated to Wenzhou Medical University,Linhai 317000;Department of Obstetrics and Gynecology,No.2 Affiliated Hospital of Wenzhou Medical University,Wenzhou 325027)

机构地区：[1]温州医科大学附属台州医院妇产科,临海317000 [2]温州医科大学附属第二医院妇产科,温州325027

出　　处：《数理医药学杂志》2021年第6期925-926,共2页Journal of Mathematical Medicine

基　　金：台州市科技计划(1902ky29);台州恩泽医疗中心(集团)科学研究基金(15EZD15)。

摘　　要：目的:探究分析左炔诺孕酮宫内缓释系统治疗功能失调性子宫出血及子宫内膜增生过长的临床疗效。方法:2018年1月~2019年1月,某院妇科一共收治功能失调性子宫出血及子宫内膜增生过长患者53例,在患者诊刮5~7d或月经5~7d给予左炔诺孕酮宫内缓释系统放置,对比治疗前后患者的情况。结果:患者治疗前、治疗后的月经量PBAC评分、血红蛋白水平、子宫内膜厚度比较,差异显著(P<0.05)。结论:左炔诺孕酮宫内缓释系统治疗功能失调性子宫出血及子宫内膜增生过长,效果显著,值得应用。Objective:To explore and analyze the clinical efficacy of levonorgestrel intrauterine sustained release system in the treatment of dysfunctional uterine bleeding and endometrial hyperplasia.Methods:From January 2018 to January 2019,a total of 53 patients with dysfunctional uterine bleeding and endometrial hyperplasia admitted to a department of gynecology were selected.Levonorgestrel intrauterine sustained release system was placed at 5~7 days after diagnosis or 5~7 days after menstruation,and the conditions of the patients before and after treatment were compared.Results:PBAC score,hemoglobin level and endometrial thickness of menstrual volume were significantly different before and after treatment(P<0.05).Conclusion:The effect of levonorgestrel intrauterine sustained release system in the treatment of dysfunctional uterine bleeding and endometrial hyperplasia is significant,which is worthy of application.

关 键 词：左炔诺孕酮宫内缓释系统 功能失调性子宫出血 子宫内膜增生过长 

分 类 号：R711.52[医药卫生—妇产科学]